Nima Farzan

Nima Farzan

Directeur/Membre du Conseil chez KEROS THERAPEUTICS, INC.

Fortune : 109 879 $ au 31/05/2026

50 ans
Health Technology
Commercial Services
Consumer Services

Profil

Nima M.
Farzan
is Chief Executive Officer at Latigo Biotherapeutics, Inc. since 2024.
Mr. Farzan is an Independent Director at Keros Therapeutics, Inc. since 2020.
Mr. Farzan is a Trustee at The Hamlin School.
Former roles include President, Chief Executive Officer & Director at Kinnate Biopharma, Inc. from 2020 to 2024.
President, Chief Executive Officer & Director at Emergent Travel Health, Inc. from 2015 to 2018.
President & Chief Executive Officer at Paxvax Corp.
from 2015 to 2018.
Director-Strategic Marketing at DoubleTwist, Inc. from 1997 to 1999.
Director-Disease Area Strategy at Novartis AG from 2003 to 2011.
Associate at The Boston Consulting Group, Inc. Vice President-Marketing at Novartis Vaccines & Diagnostics, Inc. Member of the Coalition for Epidemic Preparedness Innovations.
Venture Partner at Foresite Capital Management LLC in 2024.
Education includes undergraduate degree from Stanford University and MBA from Harvard Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/06/2026 9 767 ( 0,05 % ) 109 879 $ 31/05/2026

Postes actifs de Nima Farzan

SociétésPosteDébut
KEROS THERAPEUTICS, INC. Directeur/Membre du Conseil 01/03/2020
Corporate Officer/Principal -
Directeur Général 22/07/2024

Anciens postes connus de Nima Farzan

SociétésPosteFin
Corporate Officer/Principal 01/07/2024
KINNATE BIOPHARMA INC. Directeur Général 03/04/2024
Directeur Général 01/10/2018
Paxvax Corp.
Directeur Général 01/10/2018
NOVARTIS AG Corporate Officer/Principal 01/01/2011
Voir l'expérience en détail de Nima Farzan

Formation de Nima Farzan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

76

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées14

Commercial Services

Commercial Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Consumer Services

Finance

Consumer Services

Health Technology

Coalition for Epidemic Preparedness Innovations

Health Technology

Health Technology

Paxvax Corp.

  1. Bourse
  2. Insiders
  3. Nima Farzan
🔇